CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Palliative treatment of unresectable pancreatico-biliary cancer by either Gemcitabine or Octreotide/Imatinib – impact on biomarkers of angiogenesis
DOI 10.1055/s-2007-988197
Bibliografische Angaben
Nachweis in CareLit
Autor:innenG Treiber, T Wex, P Malfertheiner
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Gemcitabine represents standard Tx for unresectable cancers of the pancreas/distal biliary tract. Recent interest has focused on antiangiogenic properties in a mouse model of pancreatic cancer (JCI 2003); either VEGF or PDGF inhibition alone were less effective than the combination of both in terms of angiogenesis. In HCC pts. we recently evaluated the impact of biomarkers on disease progression and survival (…
Zitieren
Zitierempfehlung
G Treiber, T Wex, P Malfertheiner (2007) Palliative treatment of unresectable pancreatico-biliary cancer by either Gemcitabine or Octreotide/Imatinib – impact on biomarkers of angiogenesis. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-2007-988197
Mit CareLit weiterarbeiten